It is a healthcare private limited company based in Ujjain, Madhya Pradesh, India, established in 2005.
2005 | Ujjain, Madhya Pradesh, India | ActiveDupha Formulations (India) Private Limited, a active private limited company, was established on 25 August 2005 in Ujjain, Madhya Pradesh, India. Engaging in other hospital and medical care activities within the hospital and medical care sector, it holds CIN: U02423MP2005PTC017897. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.70 M.
It upholds a active non-compliant status. Its leadership includes Anupama Madan (Director), Aruna Singh (Director), Viny Lahiri (Director). Past directors included Rajesh Singh. It holds no open charges and ₹2.50 M settled loans. Its latest AGM occurred on 22 April 2019, with the balance sheet filed on 31 March 2019. It is based at A-1/16, Mig Iind Mahanandanagar, Ujjain, Madhya Pradesh, 456001.
U02423MP2005PTC017897
017897
25 August 2005
₹1.00 M
₹0.70 M
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Dupha Formulations (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anupama Madan | Director | 25 Aug 2005 | Current |
| Aruna Singh | Director | 25 Aug 2005 | Current |
| Viny Lahiri | Director | 25 Aug 2005 | Current |
| Rajesh Singh | Director | 25 Aug 2005 | Current |
| Deepak Singh Rathore | Director | 25 Aug 2005 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Sep 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Dupha Formulations (India) Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 93.1% decrease. The company also saw a substantial fall in profitability, with a 59.62% decrease in profit. The company's net worth dipped by a decrease of 4.27%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Dupha Formulations (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹2,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Aug 2007 | Uco Bank | ₹2.50 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Dupha Formulations (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Dupha Formulations (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dupha Formulations (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Dupha Formulations (India) Private Limited last Annual general meeting of members was held on 22 Apr 2019 as per latest MCA records. was recorded as a recent event.
Progress on Dupha Formulations (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Gwalior. was documented.
Progress on A charge registered on 01 Aug 2007 via Charge ID 10064985 with Uco Bank was fully satisfied on 18 Apr 2018. was documented.
The activity A charge with Uco Bank of Rs. 2.50 M registered on 01 Aug 2007 with Charge ID 10064985 was modified on 23 Nov 2010. was completed.
A charge with Uco Bank amounted to Rs. 2.50 M with Charge ID 10064985 was registered on 01 Aug 2007. was recorded as a recent event.
Anupama Madan was appointed as a Director was appointed as a Director on 25 Aug 2005 & has been associated with this company since 20 years 3 months . was recorded as a recent event.
The CIN of Dupha Formulations (India) Private Limited is U02423MP2005PTC017897.
Dupha Formulations (India) Private Limited is headquartered at A-1/16, Mig Iind Mahanandanagar, Ujjain, Madhya Pradesh, 456001.
Dupha Formulations (India) Private Limited was incorporated on 25 August 2005.
The current directors of Dupha Formulations (India) Private Limited are
The primary industry of Dupha Formulations (India) Private Limited is Hospital And Medical Care.
Dupha Formulations (India) Private Limited is unlisted.
The authorized capital of Dupha Formulations (India) Private Limited is ₹1.00 M, and the paid-up capital is ₹0.70 M.
The compliance status of Dupha Formulations (India) Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX